FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides.
D008671:Actinoid Series Elements / Q000378:metabolism / Q000506:poisoning*; D006801:Humans; D004369:Pentetic Acid / Q000627:therapeutic use*; D011005:Plutonium / Q000506:poisoning; D012107:Research Design; D015032:Zinc / Q000378:metabolism / Q000627:therapeutic use*
D008671:Actinoid Series Elements; D011005:Plutonium; D004369:Pentetic Acid; D015032:Zinc